NASDAQ:AHCO - Nasdaq - US00653Q1022 - Common Stock - Currency: USD
9.06
-0.19 (-2.05%)
The current stock price of AHCO is 9.06 USD. In the past month the price increased by 17.21%. In the past year, price decreased by -10.03%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 21.71 | 90.08B | ||
COR | CENCORA INC | 19.65 | 56.44B | ||
CAH | CARDINAL HEALTH INC | 19.16 | 37.04B | ||
HSIC | HENRY SCHEIN INC | 15.05 | 8.83B | ||
AHG | AKSO HEALTH GROUP | N/A | 642.10M | ||
OMI | OWENS & MINOR INC | 4.4 | 530.71M | ||
WGRX | WELLGISTICS HEALTH INC | N/A | 117.38M | ||
ATPC | AGAPE ATP CORP | N/A | 104.52M | ||
COSM | COSMOS HEALTH INC | N/A | 12.84M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 4.51M |
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 10,500 full-time employees. The company went IPO on 2018-02-21. The firm's Sleep Health segment provides sleep therapy equipment, supplies and related services (including CPAP and BiLevel services) to individuals for the treatment of obstructive sleep apnea. Its Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. Its Diabetes Health segment provides medical devices, including continuous glucose monitors and insulin pumps, and related services to patients for the treatment of diabetes. Its Wellness at Home segment provides home medical equipment and services to patients in their homes, including those who have been discharged from acute care and other facilities.
ADAPTHEALTH CORP
220 W Germantown Pike Ste 250
Plymouth Meeting PENNSYLVANIA 19462 US
CEO: Luke McGee
Employees: 10500
Phone: 16106306357
The current stock price of AHCO is 9.06 USD. The price decreased by -2.05% in the last trading session.
The exchange symbol of ADAPTHEALTH CORP is AHCO and it is listed on the Nasdaq exchange.
AHCO stock is listed on the Nasdaq exchange.
15 analysts have analysed AHCO and the average price target is 13.26 USD. This implies a price increase of 46.36% is expected in the next year compared to the current price of 9.06. Check the ADAPTHEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ADAPTHEALTH CORP (AHCO) has a market capitalization of 1.22B USD. This makes AHCO a Small Cap stock.
ADAPTHEALTH CORP (AHCO) currently has 10500 employees.
ADAPTHEALTH CORP (AHCO) has a support level at 8.99 and a resistance level at 9.07. Check the full technical report for a detailed analysis of AHCO support and resistance levels.
The Revenue of ADAPTHEALTH CORP (AHCO) is expected to grow by 0.55% in the next year. Check the estimates tab for more information on the AHCO EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AHCO does not pay a dividend.
ADAPTHEALTH CORP (AHCO) will report earnings on 2025-08-04, before the market open.
The PE ratio for ADAPTHEALTH CORP (AHCO) is 15.89. This is based on the reported non-GAAP earnings per share of 0.57 and the current share price of 9.06 USD. Check the full fundamental report for a full analysis of the valuation metrics for AHCO.
The outstanding short interest for ADAPTHEALTH CORP (AHCO) is 9.66% of its float. Check the ownership tab for more information on the AHCO short interest.
ChartMill assigns a technical rating of 3 / 10 to AHCO. When comparing the yearly performance of all stocks, AHCO turns out to be only a medium performer in the overall market: it outperformed 46.75% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to AHCO. AHCO has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months AHCO reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS increased by 140.14% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.99% | ||
ROA | 1.8% | ||
ROE | 5.14% | ||
Debt/Equity | 1.27 |
ChartMill assigns a Buy % Consensus number of 80% to AHCO. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 42.8% and a revenue growth 0.55% for AHCO